Corteva shares fall 6% on worse-than-expected Q3 results
Corteva Inc. (CTVA) reported Q3 earnings of $0.06 per share, missing estimates of $0.10, and revenue of $1.59B, below the $1.77B forecast. Shares fell 6.4%. Full-year 2026 guidance adjusted, with EPS midpoint at $0.78, above consensus, but EBITDA guidance lowered due to Brazil market conditions. Revenue declined 9% YoY, with Latin America sales down 31% and North America up 7%.
How this was made
The 30-second read
Why it matters
The earnings miss and lowered Brazil outlook drive immediate sell pressure, but full‑year EPS guidance above consensus offers a potential floor.
Market read
The report is a primary earnings disclosure with material numbers, prompting a notable price move and sector‑wide implications.
What to watch
Strong new‑product performance and 7% North America organic sales growth could mitigate the downside.
Background
Corteva is a major U.S. crop‑protection company; its earnings are closely watched by agribusiness investors.
Ticker impact
Corteva reported Q3 earnings of $0.06 EPS vs $0.10 estimate and revenue of $1.59B vs $1.77B estimate, causing a 6.4% share decline.
likely further downside as the market prices in the revenue shortfall and softer Brazil outlook
The miss is material and the stock already fell 6% on the news; no mitigating catalyst was provided.
Market effects
Crop protection sector may see broader pressure from Brazil market softness and acetochlor pricing challenges.
Latin America exposure highlighted; Brazil's farmer liquidity constraints could affect peers.
Limited to agriculture inputs; not a broad market driver.
Counterpoint
Guidance beat for full-year EPS may support a short-term bounce if investors focus on the upside.
Key entities
- companyCorteva Inc.
U.S. crop protection firm reporting Q3 results.
